全文获取类型
收费全文 | 2819篇 |
免费 | 158篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 92篇 |
妇产科学 | 57篇 |
基础医学 | 383篇 |
口腔科学 | 76篇 |
临床医学 | 197篇 |
内科学 | 627篇 |
皮肤病学 | 28篇 |
神经病学 | 233篇 |
特种医学 | 148篇 |
外科学 | 469篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 155篇 |
眼科学 | 18篇 |
药学 | 167篇 |
肿瘤学 | 316篇 |
出版年
2023年 | 12篇 |
2022年 | 48篇 |
2021年 | 64篇 |
2020年 | 30篇 |
2019年 | 62篇 |
2018年 | 72篇 |
2017年 | 47篇 |
2016年 | 65篇 |
2015年 | 82篇 |
2014年 | 116篇 |
2013年 | 131篇 |
2012年 | 176篇 |
2011年 | 188篇 |
2010年 | 101篇 |
2009年 | 93篇 |
2008年 | 151篇 |
2007年 | 153篇 |
2006年 | 134篇 |
2005年 | 127篇 |
2004年 | 113篇 |
2003年 | 105篇 |
2002年 | 100篇 |
2001年 | 72篇 |
2000年 | 75篇 |
1999年 | 68篇 |
1998年 | 29篇 |
1997年 | 29篇 |
1996年 | 36篇 |
1995年 | 34篇 |
1994年 | 19篇 |
1993年 | 15篇 |
1992年 | 49篇 |
1991年 | 46篇 |
1990年 | 31篇 |
1989年 | 43篇 |
1988年 | 43篇 |
1987年 | 24篇 |
1986年 | 31篇 |
1985年 | 15篇 |
1984年 | 12篇 |
1983年 | 20篇 |
1982年 | 10篇 |
1980年 | 10篇 |
1979年 | 17篇 |
1978年 | 12篇 |
1976年 | 12篇 |
1974年 | 7篇 |
1970年 | 6篇 |
1968年 | 6篇 |
1966年 | 12篇 |
排序方式: 共有3002条查询结果,搜索用时 0 毫秒
61.
Rivarola HW Fernández AR Enders JE Fretes R Gea S Suligoy M Palma JA Paglini-Oliva P 《Annals of tropical medicine and parasitology》1999,93(7):695-702
Thioridazine, a tricyclic drug, is known to have a direct effect on Trypanosoma cruzi, disrupting the parasites' mitochondria and kinetoplasts. In the present study, the drug was used orally, at 80 mg/kg.day for 3 days, to treat mice inoculated with low numbers of T. cruzi. The drug caused no apparent toxicity in the host. It cleared trypomastigotes from the bloodstream, prevented the histological and functional alterations of the heart normally observed in the chronic phase of the experimental disease, and greatly reduced the mortality rate compared with that in untreated, infected controls. When checked 135 days post-infection, the density of cardiac beta receptors and the cardiac histology of the treated mice were indistinguishable from those of uninfected, untreated controls. The drug is already used to treat humans, as a neuroleptic drug. It appears to be able to prevent acute infection with T. cruzi evolving into chronic disease, at least in mice, and may be a useful base from which to design new agents for the treatment of Chagas disease. 相似文献
62.
De Palma GD Galloro G Romano G Sottile R Puzziello A Persico F Masone S Labianca O Persico G 《Hepato-gastroenterology》2003,50(53):1229-1231
BACKGROUND/AIMS: The outcome of endoscopic biliary stent insertion for postoperative bile duct stenosis was retrospectively evaluated. METHODOLOGY: Fifty-seven patients with biliary stenosis from laparoscopic cholecystectomy were included from February 1992 to January 2000. One to three stents were inserted for an average of 12.4 months, with stent exchange every 3 months to avoid cholangitis caused by clogging. RESULTS: Successful stent insertion was achieved in 43/57 (75.4%) patients. Stent insertion failed in 10 patients with complete and in 4 patients with incomplete biliary obstruction. Early complications occurred in 4 patients. Late complications occurred in 5/43 patients. Five patients experienced recurrence of stenosis. CONCLUSIONS: Endoscopic treatment should be the initial management of choice for postoperative bile duct stenosis. 相似文献
63.
M.T. Pinto L.D.F. Nicolete E.S. Rodrigues P.V.B. Palma M.D. Orellana S. Kashima D.T. Covas 《Brazilian journal of medical and biological research》2013,46(8):676-680
Multipotent mesenchymal stromal cells (MSCs) were first isolated from bone marrow and
then from various adult tissues including placenta, cord blood, deciduous teeth, and
amniotic fluid. MSCs are defined or characterized by their ability to adhere to
plastic, to express specific surface antigens, and to differentiate into osteogenic,
chondrogenic, adipogenic, and myogenic lineages. Although the molecular mechanisms
that control MSC proliferation and differentiation are not well understood, the
involvement of microRNAs has been reported. In the present study, we investigated the
role of miR-125b during osteoblastic differentiation in humans. We found that
miR-125b increased during osteoblastic differentiation, as well as Runx2 and ALPL
genes. To study whether the gain or loss of miR-125b function influenced osteoblastic
differentiation, we transfected MSCs with pre-miR-125b or anti-miR-125b and cultured
the transfected cells in an osteoblastic differentiation medium. After transfection,
no change was observed in osteoblastic differentiation, and Runx2, OPN, and ALPL gene
expression were not changed. These results suggest that the gain or loss of miR-125b
function does not influence levels of Runx2, OPN, and ALPL during osteoblastic
differentiation. 相似文献
64.
Carmen Barba Massimo Cossu Renzo Guerrini Giancarlo Di Gennaro Flavio Villani Luca De Palma Laura Grisotto Alessandro Consales Domenica Battaglia Nelia Zamponi Piergiorgio dOrio Martina Revay Michele Rizzi Sara Casciato Vincenzo Esposito Pier Paolo Quarato Roberta Di Giacomo Giuseppe Didato Chiara Pastori Giusy Carfi Pavia Simona Pellacani Giulia Matta Mattia Pacetti Gianpiero Tamburrini Elisabetta Cesaroni Gabriella Colicchio Giampaolo Vatti Sofia Asioli Massimo Caulo Carlo Efisio Marras Laura Tassi 《Epilepsia》2021,62(1):128-142
65.
Nicola Specchio Chiara Pepi Luca de Palma Romina Moavero Alessandro De Benedictis Carlo Efisio Marras Federico Vigevano Paolo Curatolo 《Epileptic Disord》2021,23(1):53-73
Objective: Tuberous sclerosis complex (TSC) is a multisystem genetic disorder associated with refractory early‐onset epilepsy. Current evidence supports surgery as the intervention most likely to achieve long‐term seizure freedom, but no specific guidelines are available on TSC pre‐surgical workup. This critical review assesses which TSC patients are suitable for surgical treatment, when pre‐surgical evaluation should start, and what degree of surgical resection is optimal for postsurgical outcome. Methods: We searched for publications from 2000 to 2020 in Pubmed and Embase using the terms “tuberous sclerosis,” “epilepsy,” and “epilepsy surgery”. To evaluate postsurgical seizure outcome, we selected only studies with at least one year of follow‐up. Results: Overall, we collected data on 1,026 patients from 34 studies. Age at surgery ranged from one month to 54 years. Mean age at surgery was 8.41 years. Of the diagnostic non‐invasive pre‐surgical tools, MRI and video‐EEG were considered most appropriate. Promising data for epileptogenic tuber detection is provided from invasive SEEG studies. Data on surgery and related outcome were available for 769 patients. Seizure freedom was seen in 64.4% of patients who underwent tuberectomy, 68.9% treated with lobectomy and 65.1% with multilobar resection. The most effective surgical approach was lobectomy, even though more recently tuberectomy associated with the resection of the perituberal area seems to be the best approach to reach seizure freedom. Published postsurgical seizure freedom rates in patients with TSC were between 65% and 75%, but reduced to 48%‐57% over longer follow‐up periods. Early surgery might positively affect neurodevelopmental trajectory in some patients, even though data on cognitive outcome are still to be confirmed with longitudinal studies. Significance: Considering the strong correlation between epilepsy duration and neurocognitive outcome, all patients with TSC ought to be referred early to a dedicated epilepsy centre for individually tailored pre‐surgical evaluation by a multi‐disciplinary epilepsy surgery team. 相似文献
66.
M. Nucci M. Garnica A.B. Gloria D.S. Lehugeur V.C.H. Dias L.C. Palma P. Cappellano K.Y. Fertrin F. Carlesse B. Simões M.D. Bergamasco C.A. Cunha A. Seber M.P.D. Ribeiro F. Queiroz-Telles M.L.M. Lee M.L. Chauffaille L. Silla A.L. Colombo 《Clinical microbiology and infection》2013,19(8):745-751
Invasive fungal disease (IFD) shows distinct regional incidence patterns and epidemiological features depending on the geographic region. We conducted a prospective survey in eight centres in Brazil from May 2007 to July 2009. All haematopoietic cell transplant (HCT) recipients and patients with acute myeloid leukaemia (AML) or myelodysplasia (MDS) were followed from admission until 1 year (HCT) or end of consolidation therapy (AML/MDS). The 12-month cumulative incidence (CI) of proven or probable IFD was calculated, and curves were compared using the Grey test. Among 237 AML/MDS patients and 700 HCT recipients (378 allogeneic, 322 autologous), the 1-year CI of IFD in AML/MDS, allogeneic HCT and autologous HCT was 18.7%, 11.3% and 1.9% (p <0.001), respectively. Fusariosis (23 episodes), aspergillosis (20 episodes) and candidiasis (11 episodes) were the most frequent IFD. The 1-year CI of aspergillosis and fusariosis in AML/MDS, allogeneic HCT and autologous HCT were 13.4%, 2.3% and 0% (p <0.001), and 5.2%, 3.8% and 0.6% (p 0.01), respectively. The 6-week probability of survival was 53%, and was lower in cases of fusariosis (41%). We observed a high burden of IFD and a high incidence and mortality for fusariosis in this first multicentre epidemiological study of IFD in haematological patients in Brazil. 相似文献
67.
68.
69.
Luca Masotti Grazia Panigada Giancarlo Landini Filippo Pieralli Francesco Corradi Salvatore Lenti Rino Migliacci Stefano Arrigucci Anna Frullini Maria Chiara Bertieri Stefano Tatini Alberto Fortini Irene Cascinelli Nicola Mumoli Stefano Giuntoli Alessandro De Palma Veronica De Crescenzo Michele Piacentini Giancarlo Tintori Alba Dainelli Giuseppa Levantino Plinio Fabiani Filippo Risaliti Roberta Mastriforti Michele Voglino Valentina Carli Simone Meini 《Journal of thrombosis and thrombolysis》2016,41(4):606-612
Prognostic stratification of acute pulmonary embolism (PE) remains a challenge in clinical practice. Simplified PESI (sPESI) score is a practical validated score aimed to stratify 30-day mortality risk in acute PE. Whether prognostic value of sPESI score differs according to sex has not been previously investigated. Therefore the aim of our study was to provide information about it. Data records of 452 patients, 180 males (39.8 %) and 272 females (60.2 %) discharged for acute PE from Internal Medicine wards of Tuscany (Italy) were analysed. sPESI was retrospectively calculated. Variables enclosed in sPESI score, all cause in-hospital mortality and overall bleedings were compared between sexes. Moreover, predictive ability of sPESI score as prognosticator of all cause in-hospital mortality was tested and compared between sexes. sPESI score 0 (low risk) was found in 17.7 % of males and 13.6 % of females (p = 0.2323). We didn’t find significant difference in sPESI scoring distribution. Age ≥80 years (51.4 vs. 33.8 %, p = 0.0003) and heart rate ≥110 bpm (23.5 vs. 14.4 %, p = 0.0219) were found significantly more prevalent in females, whereas active cancer (23.8 vs. 39.4 %, p = 0.0004) and cardio-respiratory diseases (19.8 vs. 27.7 %, p = 0.0416) were in males. All cause in-hospital mortality was 0 % in both genders for sPESI score 0, whereas it was 5.4 % in females and 13.6 % in males with sPESI score 1–2 (p = 0.0208) and 22 % in females and 19.3 % in males with sPESI score ≥3 (p = 0.7776). Overall bleedings were significantly more frequent in females compared with males (4.77 vs. 0.55 %, p = 0.0189). In females overall bleedings ranged from 2.7 % in sPESI score 0 to 6 % in sPESI score ≥3. Predictive ability of sPESI score as prognosticator of all cause in-hospital mortality was higher in females compared to males (AUC 0.72 vs. 0.67, respectively). In real life different co-morbidity burdens in females compared to males. Females seems to be at lower risk of all cause in-hospital mortality for sPESI score ≤2 but at higher risk of bleeding, irrespective from sPESI scoring. Predictive ability of sPESI score seems better in females. 相似文献
70.
Our purpose was to evaluate the durability of the diagnosis of irritable bowel syndrome (IBS) based on clinical criteria. The study population consisted of a cohort of previously published study patients evaluated for IBS between 1989 and 1992, who met the International Congress of Gastroenterology criteria for IBS. Patients were reinterviewed for cardinal features of IBS, Rome I, Rome II, and Manning criteria 10-13 years after the initial diagnosis. During the observational follow-up period, there were 75 patients, 14 males and 61 females, with a mean age of 47.5 +/- 11.3 years (SD; range, 20 to 75 years). Mean time of reinterview after initial diagnosis was 11.8 +/- 0.9 years (range, 10 to 13 years). None of the 75 patients had an abdominal condition which could have been mistaken for IBS. Other abdominal conditions diagnosed during this period included diverticulitis (five), uterine fibromyoma (three), and gallbladder disease (three). Sixty-nine patients (92%) did not consider their symptoms as resolved. Thirty-five (46.7%) had repeat structural evaluation of the colon for similar symptoms without any new diagnoses made. Twenty-six (34.7%) and 32 (42.7%) presently meet the Rome II and Rome I criteria for IBS, respectively. Clinicians are advised to use clinical criteria for a specific and durable diagnosis of IBS. 相似文献